NCT00005831 Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer Status COMPLETED Phase PHASE2
NCT00005810 Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00005806 Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00005798 Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer Status COMPLETED Phase PHASE2
NCT00005631 Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00005627 Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE1
NCT00005612 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00005602 Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas Status COMPLETED Phase PHASE1
NCT00005593 Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT00005078 Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT00005065 Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00005059 Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005051 Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer Status COMPLETED Phase PHASE2
NCT00005049 Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer Status COMPLETED Phase PHASE2
NCT00005026 Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT00005024 Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease Status UNKNOWN Phase PHASE3
NCT00005021 Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma Status COMPLETED Phase PHASE1
NCT00004934 Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Status COMPLETED Phase PHASE3
NCT00004921 High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery Status COMPLETED Phase PHASE3
NCT00004906 Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2